Jasper Therapeutics, Inc.

NASDAQ:JSPR

6.15 (USD) • At close February 8, 2025
Bedrijfsnaam Jasper Therapeutics, Inc.
Symbool JSPR
Munteenheid USD
Prijs 6.15
Beurswaarde 92,258,610
Dividendpercentage 0%
52-weken bereik 5.25 - 31.01
Industrie Biotechnology
Sector Healthcare
CEO Mr. Ronald A. Martell
Website https://jaspertherapeutics.com

An error occurred while fetching data.

Over Jasper Therapeutics, Inc.

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic

Vergelijkbare Aandelen

Werewolf Therapeutics, Inc. logo

Werewolf Therapeutics, Inc.

HOWL

1.36 USD

Annexon, Inc. logo

Annexon, Inc.

ANNX

3.44 USD

UroGen Pharma Ltd. logo

UroGen Pharma Ltd.

URGN

10.715 USD

CVRx, Inc. logo

CVRx, Inc.

CVRX

14.64 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)